Skip to content

Serotonin: all studies

Page 302 of 400: studies 3,011 to 3,020 of 3,999, newest first. Back to the serotonin overview

Research

Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis

Journal of Psychopharmacology May 25, 2020 Bruno Romeo, Laurent Karila, Catherine Martelli et al. 115 citations

Background: Psychedelic drugs have shown an efficacy in some psychiatric disorders and have an original mechanism of action with a 5-HT 2A agonism. Aim: The aim of this meta-analysis was to assess by a quantitative analysis the putative efficacy of psychedelic drugs on depressive symptoms and to investigate the kinetic of this efficacy. Methods: We searched the MEDLINE and PsycINFO databases...

Chronic pain and psychedelics: a review and proposed mechanism of action

Regional Anesthesia & Pain Medicine May 4, 2020 Joel Castellanos, C. Leonard Woolley, Kelly Bruno et al. 118 citations

The development of chronic pain is a complex mechanism that is still not fully understood. Multiple somatic and visceral afferent pain signals, when experienced over time, cause a strengthening of certain neural circuitry through peripheral and central sensitization, resulting in the physical and emotional perceptual chronic pain experience. The mind-altering qualities of psychedelics have been...

DOI: 10.1136/rapm-2020-101273 (opens in new tab) Chronic pain Nociception Opioid Dissociative +7

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Neuropharmacology May 1, 2020 Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein et al. 274 citations

Serotonergic hallucinogens such as lysergic acid diethylamide (LSD) induce head twitches in rodents via 5-HT2A receptor activation. The goal of the present investigation was to determine whether a correlation exists between the potency of hallucinogens in the mouse head-twitch response (HTR) paradigm and their reported potencies in other species, specifically rats and humans. Dose-response...

Ayahuasca – potential therapeutic properties in psychiatry. Research review

Psychiatria Polska April 30, 2020 Aleksandra Barabasz-Gembczyk, Krzysztof Kucia 4 citations

Ayahuaska, zwana również „lianą duszy”, „pnączem duszy” to rytualny psychodelik podawany tradycyjnie w formie wywaru roślinnego, od stuleci stosowany przez rdzenną ludność Ameryki Południowej, a w ostatnich 25 latach również w krajach Europy, Azji, Afryki, Australii, w Kanadzie i Stanach Zjednoczonych Ameryki Północnej. Jej aktywność biologiczna wynika z zawartości N,N- dimetrylotryptaminy...

Spinal cord injury after the use of ecstasy in a young male.

Spinal cord series and cases April 28, 2020 Myrna Elena Kastaneer, Maria Christina Maijers, Juan David Martina

Ecstasy is a commonly used party drug and is the second most popular drug after marijuana among youngsters. Serious health hazards have been described including cardiac diseases, neurological complications, multi-organ failure, and even death. Spinal cord injury/dysfunction (SCI/D) is rarely described as a result of ecstasy ingestion. We present a case of a 19-year-old male patient who was...

Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy

Medical Science Monitor April 27, 2020 Jie Wang, Yajun Wang, Xudong Xu et al. 80 citations

Background This study investigated the effects of various doses of S-ketamine on depression and pain management of cervical carcinoma patients with mild/moderate depression. Material/Methods This randomized, double-blind, controlled study included 417 cervical carcinoma patients who received laparoscopic modified radical hysterectomy from April 2015 to July 2018 and who also had mild/moderate...

Psychedelics

UNC Libraries April 22, 2020 David E. Nichols

Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction. Their origin predates written history, and they were employed by early cultures in many sociocultural and ritual contexts. After the virtually...

Lysosomal Dysfunction and Autophagy Blockade Contribute to MDMA-Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells.

Chemical Research in Toxicology April 20, 2020 I-Hsun Li, Jui-Hu Shih, Ting-Yin Yeh et al.

Methylenedioxymethamphetamine (MDMA) is a psychostimulant with high abuse potential and severe neurotoxicity. According to our previous study, MDMA promotes autophagosome accumulation and contributes to cell death in cultured cortical and serotonergic neurons. However, the detailed mechanism underlying autophagy dysfunction remains unclear. Lysosomes play an important role in autophagic...

Designer drugs: mechanism of action and adverse effects

Archives of Toxicology April 1, 2020 Dino Luethi, Matthias E. Liechti 258 citations

Abstract Psychoactive substances with chemical structures or pharmacological profiles that are similar to traditional drugs of abuse continue to emerge on the recreational drug market. Internet vendors may at least temporarily sell these so-called designer drugs without adhering to legal statutes or facing legal consequences. Overall, the mechanism of action and adverse effects of designer...

DOI: 10.1007/s00204-020-02693-7 (opens in new tab) Full text (opens in new tab) Pharmacology Designer drug Mechanism of action Adverse effect +6

Psychedelic Psychiatry's Brave New World.

Cell April 1, 2020 David Nutt, David Erritzøe, Robin Carhart-Harris 330 citations

After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and...